Matches in Nanopublications for { ?s ?p "[In contrast, 21 of 39 (53.8%) patients whose tumors had reduced MRP-1/CD9 immunoreactivity and 5 of 7 patients whose primary carcinomas were not stained by the anti-MRP-1/CD9 MAb had lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP200491.RAhX-lGKUhBs5gK9VF3dsPAhENcQ7d5aHtB_EkSo2HFIc130_assertion description "[In contrast, 21 of 39 (53.8%) patients whose tumors had reduced MRP-1/CD9 immunoreactivity and 5 of 7 patients whose primary carcinomas were not stained by the anti-MRP-1/CD9 MAb had lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP200491.RAhX-lGKUhBs5gK9VF3dsPAhENcQ7d5aHtB_EkSo2HFIc130_provenance.
- assertion description "[In contrast, 21 of 39 (53.8%) patients whose tumors had reduced MRP-1/CD9 immunoreactivity and 5 of 7 patients whose primary carcinomas were not stained by the anti-MRP-1/CD9 MAb had lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP874255.RA0kjflSrQvDoSdmGIbDOICUFyIzSUMYHVL11yAH9_unc130_assertion description "[In contrast, 21 of 39 (53.8%) patients whose tumors had reduced MRP-1/CD9 immunoreactivity and 5 of 7 patients whose primary carcinomas were not stained by the anti-MRP-1/CD9 MAb had lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP874255.RA0kjflSrQvDoSdmGIbDOICUFyIzSUMYHVL11yAH9_unc130_provenance.
- NP289829.RAPN3IJAPg8D9l_K8Ix_A_GNPs_LfLKH11zolDsl1D2II130_assertion description "[In contrast, 21 of 39 (53.8%) patients whose tumors had reduced MRP-1/CD9 immunoreactivity and 5 of 7 patients whose primary carcinomas were not stained by the anti-MRP-1/CD9 MAb had lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP289829.RAPN3IJAPg8D9l_K8Ix_A_GNPs_LfLKH11zolDsl1D2II130_provenance.
- NP1317014.RA8tglIHWdPxXlNANg72rvfnWY92aqApKy4nTIvV3YDeM130_assertion description "[In contrast, 21 of 39 (53.8%) patients whose tumors had reduced MRP-1/CD9 immunoreactivity and 5 of 7 patients whose primary carcinomas were not stained by the anti-MRP-1/CD9 MAb had lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1317014.RA8tglIHWdPxXlNANg72rvfnWY92aqApKy4nTIvV3YDeM130_provenance.